Her goal is to use her built up IVD product development and performance evaluation expertise to assist diagnostic customers in demonstrating their IVD’s clinical evidence.

Annelies started her career at Innogenetics N.V. in 1995 as team member during research and development of nucleic acid based in vitro diagnostic assays and became project lead for the HLA-typing range assays in 2003.
In 2009, she joined the clinical development team as Senior Clinical Developer for Fujirebio Europe. Her major competences:

  • Product development, qualification, verification and validation of HLA typing assays
  • Analytical and clinical performance activities of nucleic acid and protein based quantitative or qualitative in vitro diagnostic assays

QARAD B.V.B.A.

ISO 13485 Certified

Follow us on:

Quicklinks

Website by Contents by Qarad Terms and conditions  Privacy policy  Cookie policy 
Close

Attention!

This website uses cookies to enhance your surfing experience.
Certain webfunctions rely on the usage of these cookies.
If you want more information regarding our cookie policy, you may visit this link.